Metastatic Castration-Sensitive Prostate Cancer," Cleveland Clinic oncologist Christopher Wee, MD, and host John Mangels ...

Men with prostate cancer who were treated with the GnRH agonist leuprolide had significantly more coronary artery plaque progression than those receiving the GnRH antagonist relugolix.

I f prostate cancer has spread to other areas of your body, your doctor may recommend androgen deprivation therapy (ADT), which halts the production of androgen hormones, especially testosterone.

Overall, serious adverse events occurred in 3.9% of patients over the 6-month study period. Use of relugolix among patients with prostate cancer is associated with stable quality of life (QoL), high ...

The UK National Institute for Health and Care Excellence (NICE) has recommended Accord's Relugolix (Orgovyx), as a treatment for advanced hormone-sensitive prostate cancer in its final draft guidance.